• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role for splenic marginal zone-B cells in autoantibody production in systemic lupus erythematosus

Research Project

Project/Area Number 18K08392
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 54020:Connective tissue disease and allergy-related
Research InstitutionFukushima Medical University

Principal Investigator

Machida Takeshi  福島県立医科大学, 医学部, 講師 (80583632)

Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Keywords全身性エリテマトーデス / Marginal zone-B細胞 / 抗dsDNA抗体 / 糸球体腎炎 / MRL/lprマウス / IFN-γ受容体 / TLR7 / SLEモデル / Marginal zone B細胞 / ループス腎炎 / 自己抗体産生
Outline of Final Research Achievements

We aimed to determine the involvement of the marginal zone-B (MZ-B) cells, which is isolated from lupus-prone mice, in autoantibody production and development of lupus-like nephritis using lupus-prone MRL/lpr mice. We generated the genetically-modified mice lacking MZ-B cells specifically, designated MZ-B-deficient MRL/lpr mice, and analyzed the mice pathophysiologically. Interestingly, the MZ-B-deficient MRL/lpr mice showed reduced levels of serum anti-dsDNA IgM and IgG3 compared to wild-type littermates, while serum anti-dsDNA IgG levels were similar in the two strains. Furthermore, all individuals of the MZ-B-deficient MRL/lpr mice did not exhibit severe glomerular lesions, while few individuals of the wild-type littermates showed glomerular inflammatory lesions. Taken together, it was strongly suggested that the MZ-B cells of lupus-prone mice are significantly involved in anti-dsDNA antibody production and development of lupus-like glomerulonephritis in lupus-prone MRL/lpr mice.

Academic Significance and Societal Importance of the Research Achievements

代表的な自己免疫疾患である全身性エリテマトーデス(SLE)の病態には、自己抗体を産生するB細胞が重要な役割を担うが、感染防御などに必須なB細胞を温存しながら悪性のB細胞亜集団を抑制する治療戦略が求められている。本研究では学術的位置づけとして、SLEの自己抗体産生と腎炎病態において、末梢B細胞の亜集団の1つである脾臓Marginal zone-B(MZ-B)細胞が関与することを明確に実証した研究である。また社会的位置づけとしては、SLEの治療における免疫抑制という副作用の可能性を低減させる新たな治療戦略の標的としてMZ-B細胞の可能性を提示した研究である。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report

Research Products

(7 results)

All 2020 2019 2018

All Journal Article (6 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 6 results,  Open Access: 2 results) Presentation (1 results)

  • [Journal Article] Anaphylatoxin Concentration in Aqueous and Vitreous Humor in the Eyes With Vitreoretinal Interface Abnormalities2020

    • Author(s)
      Yasuharu Oguchi , Tetsuju Sekiryu , Tomoko Omori , Yutaka Kato , Masashi Ogasawara , Yukinori Sugano , Kanako Itagaki , Akira Ojima , Takeshi Machida , Hideharu Sekine
    • Journal Title

      Experimental Eye Research

      Volume: 195 Pages: 108025-108025

    • DOI

      10.1016/j.exer.2020.108025

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A novel complement inhibitor sMAP-FH targeting both the lectin and alternative complement pathways2020

    • Author(s)
      Takasumi M, Omori T, Machida T, Ishida Y, Hayashi M, Suzuki T, Homma Y, Endo Y, Takahashi M, Ohira H, Fujita T, Sekine H
    • Journal Title

      The FASEB Journal

      Volume: 34 Pages: 6598-6612

    • DOI

      10.1096/fj.201902475r

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Evidence for Activation of Lectin and Classical Pathway Complement Components in Aqueous Humor of Neovascular Age-Related Macular Degeneration.2020

    • Author(s)
      Omori T, Oguchi Y, Machida T, Kato Y, Ishida Y, Ojima A, Itagaki K, Shintake H, Tomita R, Kasai A, Sugano
    • Journal Title

      Ophthalmic Research

      Volume: 63 Pages: 252-258

    • DOI

      10.1159/000503258

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Response to comment on “Cutting Edge: Role of MASP-3 in the physiological activation of factor D of the alternative complement pathway”2019

    • Author(s)
      Takeshi Machida, Manabu Hayashi, Teizo Fujita, and Hideharu Sekine
    • Journal Title

      The Journal of Immunology

      Volume: 203 Pages: 3091-3092

    • DOI

      10.4049/jimmunol.1901087

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] Cutting Edge: Role of MASP-3 in the physiological activation of factor D of the alternative complement pathway2019

    • Author(s)
      Manabu Hayashi, Takeshi Machida, Yumi Ishida, Yusuke Ogata, Tomoko Omori, Mika Takasumi, Yuichi Endo, Toshiyuki Suzuki, Masayuki Sekimata, Yoshimi Homma, Masahito Ikawa, Hiromasa Ohira, Teizo Fujita, and Hideharu Sekine
    • Journal Title

      the J Immunol

      Volume: 203 Pages: 1411-1416

    • DOI

      10.4049/jimmunol.1900605

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/lpr Mice2018

    • Author(s)
      Takeshi Machida, Natsumi Sakamoto, Yumi Ishida, Minoru Takahashi, Teizo Fujita, and Hideharu Sekine
    • Journal Title

      Frontiers in Immunology

      Volume: 9 Pages: 1191-1191

    • DOI

      10.3389/fimmu.2018.01191

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] SLEモデルMRL/lprマウスの抗dsDNA抗体産生における脾臓辺縁帯B細胞の役割2018

    • Author(s)
      町田豪、関根英治
    • Organizer
      Rheumatology Conference 2018
    • Related Report
      2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi